Search Filters

Search Results

Found 2 results

510(k) Data Aggregation

    K Number
    K252561

    Validate with FDA (Live)

    Device Name
    BTL-754FF
    Date Cleared
    2026-02-18

    (189 days)

    Product Code
    Regulation Number
    878.4810
    Age Range
    All
    Reference & Predicate Devices
    Predicate For
    N/A
    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticPediatricDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The BTL-754FF device with BTL-754-1 handpiece has the following indications for use:

    The BTL-754-1 with 2940nm is intended for use in Coagulation, vaporization, ablation or cutting of soft tissue (skin) in Dermatology, Plastic Surgery, Gynecology, General Surgery, Podiatry and Ophthalmology (skin around the eyes).

    Laser skin resurfacing procedures for the treatment of:

    • Acne scars
    • Wrinkles

    The BTL-754-1 with 1540nm is intended to be used for incision, excision, ablation, and coagulation (hemostasis) of soft tissue. The device is also indicated for the removal of pigmented lesions; photocoagulation of dermatological vascular lesions, including photothermolysis of blood vessels (treatment of facial and leg veins), for the treatment of periorbital and perioral wrinkles, for the treatment of back acne.

    The BTL-754-1 with combined 1540nm and 2940nm is intended for dermatological procedures requiring coagulation, resurfacing, and ablation of soft tissue. Procedures include skin resurfacing, treatment of wrinkles and textural irregularities.

    BTL-754-4 handpiece has the following indications for use:

    The BTL-754-4 with 2940nm in Fractional mode is intended for use in dermatological procedures requiring coagulation, resurfacing, and ablation of soft tissue. Procedures include skin resurfacing and treatment of wrinkles, rhytides, furrows, fine lines, textural irregularities, pigmented lesions, and vascular dyschromia.

    The BTL-754-4 with 1540nm in Fractional mode is intended for use in coagulation of soft tissue, skin resurfacing procedures as well as treatment of melasma, striae, acne scars and surgical scars.

    The BTL-754-4 with combined 1540nm and 2940nm in Fractional mode is intended for dermatological procedures requiring coagulation, resurfacing, and ablation of soft tissue. Procedures include skin resurfacing and treatment of wrinkles, rhytides, furrows, fine lines, textural irregularities, dyschromia and pigmented lesions.

    The BTL-754-4 with 1540nm in Macro mode is intended for use in dermatological procedures requiring skin resurfacing and coagulation of soft tissue.

    Device Description

    The BTL-754FF is a medical device containing two laser wavelengths. The parameters of each wavelength can be adjusted individually. The device allows the separate application of these wavelengths or their combination. The laser radiation is generated by solid-state lasers and delivered using an articulated arm to an applicator. The laser radiation is applied to the patient's body in a different beam pattern, depending on the applicator used. The absorption of laser radiation in the tissue leads to tissue heating, ablation, or coagulation.

    The BTL-754FF consists of a main unit, articulated mirror arm and applicators. The main unit is equipped with a color touch screen with a wide view angle that makes the device easy to use. The on-screen information informs the operator through the entire therapy procedure. The therapeutic parameters are easily set using the touch screen. During therapy, the screen displays information about therapy parameters. The device is equipped with the emergency laser stop button for immediate termination of the laser emission.

    AI/ML Overview

    N/A

    Ask a Question

    Ask a specific question about this device

    K Number
    K241270

    Validate with FDA (Live)

    Device Name
    BTL-754
    Date Cleared
    2025-01-30

    (269 days)

    Product Code
    Regulation Number
    878.4810
    Age Range
    All
    Reference & Predicate Devices
    Predicate For
    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticPediatricDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The BTL-754 device with BTL-754-4 handpiece has the following indications for use:

    The 2940nm Fractional handpiece is intended for use in dermatological procedures requiring coagulation, resurfacing, and ablation of soft tissue. Procedures include skin resurfacing and treatment of wrinkles, furrows, fine lines, textural irregularities, pigmented lesions, and vascular dyschromia.

    The 1540nm Fractional handpiece is intended for use in coagulation of soft tissue, skin resurfacing procedures as well as treatment of melasma, striae, acne scars and surgical scars.

    The combined 1540mm and 2940mm Fractional handpiece is intended for dermatological procedures requiring coagulation, resurfacing, and ablation of soft tissue. Procedures include skin resurfacing and treatment of wrinkles, rhytides, furrows, fine lines, textural irregularities, dyschromia and pigmented lesions.

    Device Description

    The BTL-754 is a medical device containing two laser wavelengths. A laser is a device that can generate light in the visible or invisible part of the electromagnetic spectrum. The generation of radiation occurs by means of so-called stimulated emission, thanks to which its beam has specific properties - the laser beam is well directed and can propagate over long distances without much divergence. It can also be focused into a very small spot where a very high intensity is achieved.

    The BTL-754 consists of a main unit, articulated mirror arm and applicator. The main unit is equipped with a color touch screen with a wide that makes the device easy to use. The onscreen information informs the operator through the entire therapy procedure. The therapeutic parameters are easily set using the touch screen. During therapy, the screen displays information about therapy parameters. The device is equipped with the Emergency laser stop button for immediate termination of the laser emission.

    AI/ML Overview

    The provided FDA 510(k) summary for the BTL-754 device does not describe a study involving an AI/Machine Learning component, nor does it specify acceptance criteria for such a system.

    Instead, the document details a medical device (a laser surgical instrument) and its substantial equivalence to a predicate device. The "Non-clinical Testing" section refers to compliance with applicable medical device safety standards and basic device performance verification, typical for hardware medical devices, not AI/ML performance. The "Clinical Testing" section explicitly states "Not applicable to this submission".

    Therefore, I cannot extract the requested information regarding acceptance criteria and the study proving the device meets them, as the provided text does not contain any reference to AI/ML device performance or associated studies.

    The information provided is geared towards demonstrating the BTL-754 is substantially equivalent to a legally marketed predicate device (Palomar Icon Aesthetic System, K142376) based on intended use, technological characteristics, and safety standards for laser surgical instruments.

    Ask a Question

    Ask a specific question about this device

    Page 1 of 1